Thermo Fisher Pays $1.7 Billion for Brammer Bio

31.03.2019 - US science services company Thermo Fisher Scientific has agreed to buy Brammer Bio for around $1.7 billion, the latest in a spate of gene therapy acquisitions this year by major...